Lv1
40 积分 2024-03-18 加入
Comparison of outcome, clinical, laboratory, and immunological features in 164 children and adults with T-ALL. The Groupe d'Etude Immunologique des Leucémies
17小时前
已关闭
Hemophagocytic lymphohistiocytosis: A disorder of T cell activation, immune regulation, and distinctive immunopathology
15天前
已完结
Childhood Langerhans cell histiocytosis hematological involvement: severity associated with BRAFV600E loads
15天前
已完结
Deciphering Langerhans cell histiocytosis
15天前
已关闭
The changing landscape of pediatric histiocytoses: Birth, life, and transdifferentiation of pediatric histiocytes
15天前
已完结
CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study
2个月前
已完结
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study
2个月前
已完结
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL
4个月前
已完结
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL
4个月前
已关闭
Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia
4个月前
已完结
皖公网安备34019202002308
